VivoSeq
Other

Midazolam

0

Pipeline Programs↗

3

Active Trials↗

31

Companies Involved↗

Midazolam is an early-stage landscape with 0 programs across 31 companies. The most active players are Boehringer Ingelheim, AstraZeneca, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Boehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalIdorsia Pharmaceuticals Ltd. logo

Idorsia Pharmaceuticals Ltd.

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

118

clinical trials

Completed101 · 86%
Terminated6 · 5%
Unknown status4 · 3%
Withdrawn3 · 3%
Recruiting2 · 2%
Suspended1 · 1%
Other1 · 1%

Clinical Trials

Trial Activity

118 trials

A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC
Recruiting·Jiangsu Hansoh Pharmaceutical Co., Ltd. logoJiangsu Hansoh Pharmaceutical Co., Ltd.·Phase 1·NCT06926413·20 enrolled
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
Recruiting·KKaruna Therapeutics·Phase 1·NCT07118215·60 enrolled
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
Active, not recruiting·Pfizer logoPfizer·Phase 1·NCT07190430·16 enrolled
A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT05258110·15 enrolled
Nasogastric Tube Insertion Using Midazolam in the Emergency Department
Completed·UUniversity of Vermont·Phase 4·NCT01375634·49 enrolled
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
Completed·BBioVersys AG·Phase 1·NCT05537090·16 enrolled
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT02208882·24 enrolled
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT03111511·18 enrolled
Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy
Completed·SShandong University·N/A·NCT01053871·104 enrolled
The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers
Completed·National Institutes of Health Clinical Center (CC)·Phase 1·NCT03831971·26 enrolled
A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT05901714·65 enrolled
Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration
Completed·UUniversity of Alabama at Birmingham·N/A·NCT02396537·77 enrolled
Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine
Completed·IIsfahan University of Medical Sciences·Phase 2/3·NCT01807429·236 enrolled
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
Completed·AstraZeneca logoAstraZeneca·Phase 1·NCT01069822·46 enrolled
A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants
Completed·AstraZeneca logoAstraZeneca·Phase 1·NCT06547164·40 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)